NCT06918275

Brief Summary

To evaluate postoperative outcomes in patients with isthmocele undergoing laparoscopic repair, comparing the efficacy of V-LocTM 180 and Polyglactin 910 Vicryl sutures. Patients were randomized to undergo laparoscopic isthmocele repair using one of the following suture materials: (1) V-LocTM 180 or (2) Polyglactin 910 Vicryl.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 9, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

May 30, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2026

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

July 17, 2025

Status Verified

July 1, 2025

Enrollment Period

9 months

First QC Date

March 28, 2025

Last Update Submit

July 16, 2025

Conditions

Keywords

isthmocelelaparoscopypostmenstrual bleedingV-LocTM 180Polyglactin 910

Outcome Measures

Primary Outcomes (1)

  • Post-operative residual myometrial thickness

    Ultrasonographic evaluation will be performed in the 12th postoperative month to measure residual myometrial thickness and assess the anatomical success of the repair.

    1 year

Secondary Outcomes (2)

  • Patient satisfaction and quality of life

    1 year

  • 3.Patient satisfaction

    1 year

Study Arms (2)

laparoscopic isthmocele repair using V-LocTM 180 barbed suture

ACTIVE COMPARATOR

The isthmocele area will be sutured using V-LocTM 180 barbed suture in a continuous, non-locked fashion. The repair was performed using a two-layer closure technique, ensuring precise reapproximation of the myometrial edges without breaching the uterine cavity, followed by closure of the serosal edges.

Procedure: Laparoscopic isthmocele repair using V-LocTM 180 barbed suture

laparoscopic isthmocele repair using Polyglactin 910 Vicryl sutures

ACTIVE COMPARATOR

The isthmocele area will be sutured using Polyglactin 910 Vicryl sutures in a continuous, non-locked fashion. The repair was performed using a two-layer closure technique, ensuring precise reapproximation of the myometrial edges without breaching the uterine cavity, followed by closure of the serosal edges.

Other: Laparoscopic isthmocele repair using Polyglactin 910 vicryl suture

Interventions

The standardized surgical steps for the laparoscopic isthmocele repair were as follows; 1) A 30-degree telescope was introduced through a 10 mm trocar at the umbilicus following the establishment of pneumoperitoneum. 2) Three 5 mm trocars were inserted: two in the bilateral lower quadrants and one in the suprapubic region. 3) The bladder was distended with 300 cc of saline infusion to facilitate dissection of the vesicovaginal space and to allow inferior mobilization of the bladder, thereby ensuring optimal visualization of the isthmocele region. Dissection was performed laterally up to the level of the uterine arteries, thereby minimizing the risk of vascular injury. 4) The light source of the laparoscope was deactivated, enabling the identification of the isthmocele region by utilizing the illumination provided by the hysteroscope. 5) Excision of the abnormal tissue was carried out using an ultrasonic energy device (HARMONIC®), guided by the manipulator shaft as a landmark.

laparoscopic isthmocele repair using V-LocTM 180 barbed suture

The standardized surgical steps for the laparoscopic isthmocele repair were as follows; 1) A 30-degree telescope was introduced through a 10 mm trocar at the umbilicus following the establishment of pneumoperitoneum. 2) Three 5 mm trocars were inserted: two in the bilateral lower quadrants and one in the suprapubic region. 3) The bladder was distended with 300 cc of saline infusion to facilitate dissection of the vesicovaginal space and to allow inferior mobilization of the bladder, thereby ensuring optimal visualization of the isthmocele region. Dissection was performed laterally up to the level of the uterine arteries, thereby minimizing the risk of vascular injury. 4) The light source of the laparoscope was deactivated, enabling the identification of the isthmocele region by utilizing the illumination provided by the hysteroscope. 5) Excision of the abnormal tissue was carried out using an ultrasonic energy device (HARMONIC®), guided by the manipulator shaft as a landmark.

laparoscopic isthmocele repair using Polyglactin 910 Vicryl sutures

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The study will include women aged 18-45 years who present with symptomatic isthmocele.
  • Participants must have a residual myometrial thickness of less than 2.5 mm.
  • Participants must desire future fertility.

You may not qualify if:

  • Age below 18 or above 45 years
  • Atypical endometrial cells or cervical dysplasia on cytology
  • Asymptomatic isthmocele
  • Candidacy for hysteroscopic surgery
  • Cervical or pelvic infections
  • Cervical dilation of 4 cm or more (emergency surgery)
  • Conditions impairing tissue healing, such as:
  • Type 1 or Type 2 diabetes mellitus
  • Hematologic disorders associated with bleeding diathesis
  • Contraindications for spinal or general anesthesia
  • Continuous use of oral contraceptives (OCPs) or GnRH agonists that affect menstrual cycles
  • Hydrosalpinx communicating with the uterine cavity
  • Intrauterine device (IUD) in place
  • Known connective tissue disorders
  • Menstrual irregularities:
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Basaksehir Cam and Sakura City Hospital

Istanbul, Istanbul, 34480, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 9, 2025

Study Start

May 30, 2025

Primary Completion

February 15, 2026

Study Completion

March 15, 2026

Last Updated

July 17, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations